Epiphany Dermatology, P.A.

Epiphany Dermatology focuses on delivering a comprehensive range of dermatological services, emphasizing skin cancer prevention and treatment, cosmetic procedures, and general dermatology to enhance skin health and well-being. Founded in 2014, Epiphany Dermatology, P. A. is based in Austin, US.

The company specializes in dermatology services and has expanded its operations since inception. Gheorghe P. serves as both the CEO and founder, bringing experience in the healthcare sector. In February 2022, Leonard Green & Partners acquired Epiphany Dermatology from CI Capital Partners, allowing the company to continue its growth trajectory under the leadership of its existing management team.

Epiphany Dermatology specializes in a comprehensive suite of dermatologic services aimed at addressing a range of skin health concerns. Their offerings include skin cancer prevention, screenings, and treatment, emphasizing early detection with cure rates nearing 99%. Additionally, the company provides services such as acne treatment, cosmetic procedures, and general dermatology. They offer products like Juvéderm, a collection of hyaluronic acid fillers, and body contouring treatments such as CoolSculpting and EMSculpt.

With multiple locations in the US, including Arizona, Colorado, Maryland, and Texas, Epiphany aims to serve a diverse clientele. Epiphany Dermatology generated revenue of USD 15. 20 mn in 2017. The company's revenue model relies on direct transactions with patients for various dermatological services and products.

Clients pay per service, allowing for a transactional structure tailored to individual needs. Services such as Mohs surgery and cosmetic procedures are billed individually, contributing to the overall revenue while fostering strong relationships with clients through personalized care plans. The acquisition by Leonard Green & Partners in February 2022 is expected to facilitate Epiphany Dermatology's growth and expansion into underserved markets. The investment will support initiatives to enhance access to high-quality skincare.

The company aims to develop and launch new products, though specific details regarding these products and their release dates are not provided. Epiphany Dermatology is positioned to leverage its recent funding to explore new geographic regions and broaden its service offerings.